Use of targeted nitroxide agents in bone healing
AssigneeUniversity of Pittsburgh—Of the Commonwealth System of Higher Education
InventorsMichael W. Epperly, Abhay Sudhir Gokhale, Joel S. Greenberger, Peter Wipf, Julianne Glowacki
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and related methods useful for accelerating bone healing and growth. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity.
Claims27
A method of accelerating bone healing, growth or repair in a subject, comprising administering to the subject prior to, during or after bone injury, damage or deficiency in the subject, a composition comprising an amount of a targeted nitroxide compound effective to accelerate bone repair in the subject, wherein the targeted nitroxide compound comprises a mitochondria targeting group and a nitroxide-containing group.
- wherein the targeted nitroxide compound is chosen from one of:
- a). a compound having the structure:
- wherein X is one of
- R1 and R2 are C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted, R4 is hydrogen, C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted;
- R3 is —NH—R5, —O—R5 or —CH2—R5, and R5 is an —N—O., —N—OH or N═O containing group;
- R is —C(O)—R6 or —C(O)O—R6, and R6 is C1-C6 straight or branched-chain alkyl or C1-C6 straight or branched-chain alkyl further comprising one or more phenyl (—C6H5) groups that are independently unubstituted, or methyl-, ethyl-, hydroxyl- or fluoro-substituted, and wherein the compound is not XJB-5-208;
- b). a compound having the structure R1—R2—R3 in which R1 and R3 are the same or different and have the structure —R4—R5, in which R4 is a mitochondria targeting group and R5 is —NH—R6, —O—R6 or —CH2—R6, wherein R6 is an —N—O., —N—OH or N═O containing group and R4 and R5 for each of R1 and R3 may be the same or different;
- and R2 is a linker;
- and
- c. from 2-10 consecutive amino acids of a gramicidin S polypeptide attached to a nitroxide-containing group.
The method of claim 8, in which R1 and R3 have any structure depicted in claims 1-19.
Use of a compound chosen from one of:
- a). a compound having the structure:
- wherein X is one of
- R1 and R2 are C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted, R4 is hydrogen, C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted;
- R3 is —NH—R5, —O—R5 or —CH2—R5, and R5 is an —N—O., —N—OH or N═O containing group;
- R is —C(O)—R6 or —C(O)O—R6, and R6 is C1-C6 straight or branched-chain alkyl or C1-C6 straight or branched-chain alkyl further comprising one or more phenyl (—C6H5) groups that are independently unubstituted, or methyl-, ethyl-, hydroxyl- or fluoro-substituted, and wherein the compound is not XJB-5-208;
- b). a compound having the structure R1—R2—R3 in which R1 and R3 are the same or different and have the structure —R4—R5, in which R4 is a mitochondria targeting group and R5 is —NH—R6, —O—R6 or —CH2—R6, wherein R6 is an —N—O., —N—OH or N═O containing group and R4 and R5 for each of R1 and R3 may be the same or different;
- and R2 is a linker;
- and
- c. from 2-10 consecutive amino acids of a gramicidin S polypeptide attached to a nitroxide-containing group for the preparation of a medicament for bone healing or for treating or preventing bone degeneration, optionally in osteoporosis.
The use of a compound chosen from one of:
- a). a compound having the structure:
- wherein X is one of
- R1 and R2 are C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted, R4 is hydrogen, C1-C6 straight or branched-chain alkyl, or a C1-C6 straight or branched-chain alkyl further comprising a phenyl (C6H5) group, that is unsubstituted or is methyl-, hydroxyl- or fluoro-substituted;
- R3 is —NH—R5, —O—R5 or —CH2—R5, and R5 is an —N—O., —N—OH or N═O containing group;
- R is —C(O)—R6 or —C(O)O—R6, and R6 is C1-C6 straight or branched-chain alkyl or C1-C6 straight or branched-chain alkyl further comprising one or more phenyl (—C6H5) groups that are independently unubstituted, or methyl-, ethyl-, hydroxyl- or fluoro-substituted, and wherein the compound is not XJB-5-208;
- b). a compound having the structure R1—R2—R3 in which R1 and R3 are the same or different and have the structure —R4—R5, in which R4 is a mitochondria targeting group and R5 is —NH—R6, —O—R6 or —CH2—R6, wherein R6 is an —N—O., —N—OH or N═O containing group and R4 and R5 for each of R1 and R3 may be the same or different;
- and R2 is a linker;
- and
- c. from 2-10 consecutive amino acids of a gramicidin S polypeptide attached to a nitroxide-containing group for bone healing or for treating or preventing bone degeneration, optionally associated with osteoporosis.
Dependencies are inferred from the claim text.